A photo of Daniel Lovell.

Associate Director, Division of Rheumatology

Professor, UC Department of Pediatrics

513-636-4676

513-636-5990

Board Certified

Best Doctors logo

My Biography & Research

Clinical Interests

Diagnostic evaluation and ongoing care of children with all pediatric onset rheumatic diseases

Research Interests

Performance of clinical trials in children with rheumatic diseases; clinical trials methodology; mentoring of junior faculty

Academic Affiliation

Professor, UC Department of Pediatrics

Departments

Rheumatology, Lupus, Rheumatology

My Locations

My Education

MD: University of Kansas, Kansas City, KS, 1978.

MPH: University of Texas School of Public Health, Houston, TX, 1982.

Residency: Children's Mercy Hospital, Kansas City, KS.

Fellowship: Baylor College of Medicine, Houston, TX.

Certification: Pediatrics, 1984; Pediatric Rheumatology, 1992.

My Publications

Establishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop. Morgan, EM; Munro, JE; Horonjeff, J; Horgan, B; Shea, B; Feldman, BM; Clairman, H; III, BC O; Thornhill, S; Strand, V; et al. The Journal of rheumatology. 2019; 46:1006-1013.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Angeles-Han, ST; Ringold, S; Beukelman, T; Lovell, D; Cuello, CA; Becker, ML; Colbert, RA; Feldman, BM; Holland, GN; Ferguson, PJ; et al. Arthritis and Rheumatology. 2019; 71:864-877.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis. Angeles-Han, ST; Ringold, S; Beukelman, T; Lovell, D; Cuello, CA; Becker, ML; Colbert, RA; Feldman, BM; Holland, GN; Ferguson, PJ; et al. Arthritis Care and Research. 2019; 71:703-716.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Ringold, S; Angeles-Han, ST; Beukelman, T; Lovell, D; Cuello, CA; Becker, ML; Colbert, RA; Feldman, BM; Ferguson, PJ; Gewanter, H; et al. Arthritis Care and Research. 2019; 71:717-734.

2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis. Ringold, S; Angeles-Han, ST; Beukelman, T; Lovell, D; Cuello, CA; Becker, ML; Colbert, RA; Feldman, BM; Ferguson, PJ; Gewanter, H; et al. Arthritis and Rheumatology. 2019; 71:846-863.

Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Consolaro, A; Giancane, G; Alongi, A; van Dijkhuizen, EH P; Aggarwal, A; Al-Mayouf, SM; Bovis, F; De Inocencio, J; Demirkaya, E; Flato, B; et al. The Lancet Child and Adolescent Health. 2019; 3:255-263.

Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Hinze, CH; Foell, D; Johnson, AL; Spalding, SJ; Gottlieb, BS; Morris, PW; Kimura, Y; Onel, K; Li, SC; Grom, AA; et al. Arthritis and Rheumatology. 2019; 71:451-459.

Clinical Features and Treatment of Down Syndrome Arthropathy: Experience from Two US Tertiary Hospitals. Jones, JT; Talib, N; Lovell, D; Becker, ML. Pediatric Drugs. 2019; 21:33-39.

Clinical trials in children and adolescents with systemic lupus erythematosus: methodological aspects, regulatory landscape and future opportunities. Brunner, HI; Martini, A; Lovell, DJ; Ruperto, N; Or, PR I T; Collaborative, PR. Annals of the Rheumatic Diseases. 2019; 78:162-170.

Toward New Classification Criteria for Juvenile Idiopathic Arthritis: First Steps, Pediatric Rheumatology International Trials Organization International Consensus. Martini, A; Ravelli, A; Avcin, T; Beresford, MW; Burgos-Vargas, R; Cuttica, R; Ilowite, NT; Khubchandani, R; Laxer, RM; Lovell, DJ; et al. The Journal of rheumatology. 2019; 46:190-197.